Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine versus Ondansetron for prevention of intrathecal opioid-induced pruritus after cesarean delivery
TCTR20241022009Phase 2Completed
- Sponsor
- Anesthesiologist
- Start
- Aug 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nalbuphine, ondansetron in pruritus, sponsored by Anesthesiologist. Started Aug 2024; status: completed.
02
Drugs
nalbuphineondansetron
03
Conditions
pruritus
Beyond the preview
Go deeper on TCTR20241022009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20241022009.